(R to L) EY's Ricardo Vilanova, Lila Bioscience's Molly Gibson, Merck's Iya Khalil, Insitro's Mary Rozenman, and Gallop Oncology's Luba Greenwood at BIO 2025. When Google shook the foundations of the ...
WIRED spoke with Boris Cherny, head of Claude Code, about how the viral coding tool is changing the way Anthropic works.
Your chronological age can’t always tell you the state of your health, which is why biological clocks have been developed to show our risk of developing diseases or dying – but they’re not all they ...
The structurally similar cytokines IL-2 and IL-15, and their shared beta subunit CD122, are keeping developers busy across a range of indications. Though some scientific confusion has plagued the ...
Northwest Biotherapeutics, Inc., a biotechnology company, focuses on developing personalized immune therapies for cancer. The company develops DCVax, a platform technology that uses activated ...
UK banks commit to $15 billion lending package to help firms expand abroad Britain's five leading banks - NatWest, HSBC, Barclays, Lloyds and Santander - on Monday committed to lending a combined 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results